Lotus Bio-Technology Development Corp.
Other OTCTotal Valuation
Lotus Bio-Technology Development Corp. carries a market capitalization of 8.06M, placing it among publicly traded companies globally.
| Market Cap | 8.06M |
| Enterprise Value | N/A |
Share Statistics
Lotus Bio-Technology Development Corp. currently has 782.78M shares outstanding.
| Shares Outstanding | 782.78M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
| PE Ratio | N/A |
| PS Ratio | N/A |
| PB Ratio | -3.94 |
| P/TBV Ratio | -59.68 |
| P/FCF Ratio | 203.08 |
| P/OCF Ratio | 203.08 |
Financial Position
Lotus Bio-Technology Development Corp. maintains a current ratio of 0.75, meaning it holds 0.8x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 0.75 |
| Quick Ratio | 0.75 |
| Debt / Equity | N/A |
| Debt / EBITDA | N/A |
| Interest Coverage | N/A |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -2,612.63 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Stock Price Statistics
Lotus Bio-Technology Development Corp.'s stock has gained approximately 0% over the past 52 weeks. The 50-day moving average sits at 0.01, while the 200-day moving average is 0.01.
| Beta (5Y) | N/A |
| 52-Week Price Change | 0% |
| 50-Day Moving Average | 0.01 |
| 200-Day Moving Average | 0.01 |
| Average Volume (20 Days) | N/A |
Income Statement
EBITDA reached -774,982.00, while operating income came in at -774,436.00.
| Revenue | N/A |
| Gross Profit | N/A |
| Operating Income | -774,436.00 |
| Pretax Income | -774,436.00 |
| Net Income | -774,436.00 |
| EBITDA | -774,982.00 |
| EBIT | -774,436.00 |
| Earnings Per Share (EPS) | 0.00 |
Balance Sheet
Total book value stands at -928,571.00, with working capital of -16,766.00 providing operational flexibility.
| Cash & Cash Equivalents | 50,005.00 |
| Total Debt | N/A |
| Net Debt | -50,005.00 |
| Equity (Book Value) | -928,571.00 |
| Book Value Per Share | -0.01 |
| Working Capital | -16,766.00 |
Cash Flow
Lotus Bio-Technology Development Corp. produced 18,018.00 in operating cash flow over the past twelve months.
| Operating Cash Flow | 18,018.00 |
| Capital Expenditures | N/A |
| Free Cash Flow | 18,018.00 |
| FCF Per Share | 0.00 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | 0.53 |
| FCF Yield | 0.49 |
Stock Splits
Lotus Bio-Technology Development Corp.'s most recent stock split took place on June 26, 2014 with a 1:30 split ratio.
| Last Split Date | 6/26/2014 |
| Split Ratio | 1:30 |
Scores
Lotus Bio-Technology Development Corp. posts an Altman Z-Score of -51.10, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -51.10 |